Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1542
http://purl.obolibrary.org/obo/NCIT_C1542
|
|---|---|
| Preferred Name | Pibrozelesin |
| Definitions |
A semisynthetic water-soluble derivative of the antineoplastic antibiotic duocarmycin B2. Activated by carboxyl esterase, pibrozelesin alkylates DNA by binding to adenine-thymine (A-T)-rich sequences in the minor groove of DNA, thereby inhibiting DNA replication and inducing apoptosis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A semisynthetic water-soluble derivative of the antineoplastic antibiotic duocarmycin B2. Activated by carboxyl esterase, pibrozelesin alkylates DNA by binding to adenine-thymine (A-T)-rich sequences in the minor groove of DNA, thereby inhibiting DNA replication and inducing apoptosis. |
|---|---|
| prefLabel | Pibrozelesin
|
| label | Pibrozelesin
|
| PDQ_Closed_Trial_Search_ID | 42429
|
| code | C1542
|
| prefixIRI | NCIT:C1542
|
| in_subset | |
| Preferred_Name | Pibrozelesin
|
| FDA_UNII_Code | IHK933KCIC
|
| Contributing_Source | FDA
|
| Chemical_Formula | C32H36BrN5O8
|
| Maps_To | Pibrozelesin
|
| CAS_Registry | 154889-68-6
|
| NCI_Drug_Dictionary_ID | 42429
|
| Legacy Concept Name | KW_2189
|
| type | |
| ALT_DEFINITION | A semisynthetic anticancer drug that is a type of antitumor antibiotic.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42429
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
Antibiotic
|
| UMLS_CUI | C0254093
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |